Our story
Our brands
Our commitments
News & features
EN
Return to menu
Connecting care across the world through our global reach
Our locations
Learn about Kenvue in your area
Argentina
Spanish
Brazil
Portuguese
Central America
Spanish
Chile
Spanish
Colombia
Spanish
Germany
German
India
English
Japan
Japanese
Mexico
Spanish
United Kingdom
English
Global site languages
Deutsch
English
Español
Français
Italiano
日本語
中文
Português
Investors
Healthcare professionals
Careers
Media
Investors
Healthcare professionals
Careers
Media
Menu
Close
Our story
Our brands
Our commitments
News & features
EN
Return to menu
Connecting care across the world through our global reach
Our locations
Learn about Kenvue in your area
Argentina
Spanish
Brazil
Portuguese
Central America
Spanish
Chile
Spanish
Colombia
Spanish
Germany
German
India
English
Japan
Japanese
Mexico
Spanish
United Kingdom
English
Global site languages
Deutsch
English
Español
Français
Italiano
日本語
中文
Português
Search Query
Search
Show Search
Search results - A new view of care
Search
591 Results
591 Results
Sort By
Relevance
Newest
Oldest
Kenvue announces participation in the Morgan Stanley Global Consumer & Retail Conference
November 25, 2024
Neutrogena® launches breakthrough collaboration with two of world’s most recognizable dermatologists
America’s #1 facial skincare
1
brand expanding and accelerating collaboration with dermatologists to foster innovation
October 31, 2024
Kenvue Canada expands Ontario manufacturing facility to boost production of over-the-counter medicines
Guelph facility manufactures more than 100 different medications including Tylenol®, Motrin®, Benylin® and Sudafed®
November 5, 2024
Supporting healthier smiles: How Kenvue is bringing oral health education to underserved communities
Statement in response to Texas AG filing
November 6, 2025
Listerine® and Neutrogena® named to Fast Company’s 2025 Brands That Matter list
Two Kenvue brands recognized for cultural relevance and emotional connection with consumers
December 2, 2025
Kenvue reports third quarter 2025 results
•
Net sales (3.5)%; organic sales
1
(4.4)%
•
Diluted EPS was $0.21; adjusted diluted EPS
1
was $0.28
•
Affirms outlook for FY’25
•
Kirk Perry named permanent Chief Executive Officer and company announced additional key leadership appointments
November 3, 2025
Previous
27 of 85
Next
